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Preface 
The work comprised in this thesis was carried out at the Center for Sensory-Motor Interaction 
(SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, 
Denmark, and at the Parker Institute, Department of Rheumatology, Copenhagen University 
Hospital, Bispebjerg and Frederiksberg, Copenhagen F, Denmark, in the period 2009-2013. The 
studies were performed under the supervision of Professor, DMSc Thomas Graven-Nielsen (main 
supervisor), Center for Sensory-Motor Interaction (SMI), Department of Health Science and 
Technology, Faculty of Medicine, Aalborg University; Professor, MD, DMSc Henning Bliddal (clinical 
project supervisor), and Senior Researcher, PT, PhD Marius Henriksen (project supervisor), both 
the Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg 
and Frederiksberg. The thesis is based on the three papers listed below, which are referred to in 
roman numerals in the text. The manuscripts are enclosed as Appendix A. 
 
 
Study I 
Joergensen TS, Henriksen M, Danneskiold-Samsoee B, Bliddal H, Graven-Nielsen T. Experimental 
Knee Pain Evoke Spreading Hyperalgesia and Facilitated Temporal Summation of Pain. Pain Med 
2013. 
Study II 
Jorgensen TS, Graven-Nielsen T, Ellegaard K, Danneskiold-Samsoe B, Bliddal H, Henriksen M. Intra-
Articular Analgesia and Steroid Reduce Pain Sensitivity in Knee OA Patients: An Interventional 
Cohort Study. Pain Res Treat 2014;2014:710490. 
Study III 
Jørgensen TS., Henriksen M., Rosager S., Klokker L., Ellegaard K., Danneskiold-Samsøe B., Bliddal 
H., Graven-Nielsen T. The Dynamics of the Pain System Is Intact in Patients with Knee 
Osteoarthritis: An Experimental Study. Submitted to Scan J Pain, 2014. 
 
The PhD thesis is submitted to the Faculty of Medicine, 
 Aalborg University, Denmark, September 2014 
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Introduction 
Despite the high prevalence of knee osteoarthritis (OA) it remains one of the most frequent knee 
disorders without a cure. Pain and disability are prominent clinical features of knee OA [1;2]. The 
diagnosis is based on clinical presentation supported by radiography. Except for pain, the main 
features that suggest the diagnosis include stiffness, reduced movement, swelling and crepitus [2]. 
It is estimated that up to 40% of individuals with radiologic evidence of damage have no pain [3;4] 
and that there is no clear relationship between the findings of radiologic imaging and sensory 
symptoms reported by the patients [3;5-7]. The use of more advanced imaging techniques, such as 
magnetic resonance imaging (MRI), has not clarified the source of pain in OA [8].  
A literature review indicates that psychological factors such as depression and anxiety may 
partially explain the apparent discordance between objective measures and subjective pain 
reports [9]. However, it is unlikely that such wide variability in population estimates can be 
attributed to psychological factors alone. 
From its nature OA pain is likely to be nociceptive. Nociceptive pain results from noxious 
stimulation or inflammation/injury of tissue [10]. It is usually localised to the joint with OA, but can 
also be referred [11]. Hyperalgesia and spontaneous pain in knee OA [12] are most likely related to 
increased sensitivity of nociceptors located in deep tissue (peripheral sensitisation) and/or to 
increased responses in dorsal horn or supraspinal neurons (central sensitisation) [1;12-15]. It 
varies in intensity and is usually worsened by exercise and relieved at rest [11]. It is often episodic 
but may be constantly present in advanced OA. 
The treatment of knee OA is symptomatic and involves alleviating pain, attempting to 
rectify mechanical malalignment, and identifying and addressing manifestations of joint instability 
[2;16]. In the short term pharmacologic therapy with intra-articular glucocorticosteroid (steroid) 
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therapy is long established as having a moderate effect size unlike most OA therapies and is widely 
used in clinical practice [17]. However, the mechanism of the therapeutic effect in knee OA is 
unclear [18-20] and whether or not the anti-inflammatory effects of intra-articular 
glucocorticosteroid have an effect on the increased pain sensitisation in patients with knee OA is 
unknown. 
 
Aims 
In the modern industrialised world musculoskeletal disorders, often in the form of joint pain, 
constitute a major problem. Nonetheless, some of the mechanisms underlying the pain are 
unknown. To optimally treat this common disease, an understanding of causes of pain is needed. 
Especially, knowledge of how joint pain affects the pain systems will provide important new 
insight and help to explain the basic pain mechanisms in humans. The overarching aim of this 
thesis is to provide more in-depth knowledge about pain mechanisms in knee OA. More 
specifically, the aim is to identify the responses to knee pain modulation in healthy subjects and in 
patients with knee OA, respectively, and to explore how inflammation interacts with the pain 
system in patients with knee OA. 
 
Hypotheses 
The hypotheses of the thesis are: 
 
1. Experimental knee joint pain in healthy subjects evokes local and regional hyperalgesia and 
the central mechanisms of temporal summation of pain. 
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2. Local and regional hyperalgesia and temporal summation are related to peripheral 
nociception in patients with knee OA. 
 
3. Intra-articular anti-inflammation reduces local and regional hyperalgesia and temporal 
summation of pain. 
 
 
                                                    Figure 1 Schematic representation of the PhD project 
 
Knee osteoarthritis 
Epidemiology 
OA is the most common form of arthritis. It affects growing numbers of people in aging 
populations and is more common in women than men [16;21;22] and consequently has a 
significant individual and societal impact [22-24]. The risk of mobility limitations (defined as 
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needing help to walk or climb stairs) attributable to knee OA alone is greater than those caused by 
any other medical condition in people aged 65 and over [25;26]. 
Factors that drive the development of OA include numerous individual factors, such as age, 
sex, obesity and genetics, as well as joint-specific factors that are likely reflective of abnormal 
loading of the joints [21;24] 
 
Aetiology and pathogenesis 
OA is the clinical and pathological outcome of a range of disorders that result in structural and 
functional failure of synovial joints [2;27]. Standard objective assessment of pathologic changes in 
the joint is typically accomplished via radiography, evaluating the presence of osteophytes and 
joint space narrowing [2;16;28] (Figure 2).  Traditionally, it has been considered a disease of 
articular cartilage, but the current concept holds that OA involves the entire joint organ [16].  
 
 
 
 
 
 
 
 
 
Recently the significance of inflammation and enzymatic cartilage degradation in the 
pathogenesis of OA has been stressed as important drivers of OA progression [29]. Pathologically, 
OA is characterised by degradation of type II collagen and cartilage destruction, synovitis, and 
 
Figure 2 One osteoarthritic knee with 
medial joint space narrowing confirmed 
by radiography (A) and a healthy knee (B) 
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bone marrow lesions, and in the long term all tissues of the joint and related structures are 
affected [29].  
Further, it has been suggested that joint pain results from mild inflammation in joint 
structures such as the synovial layer. Imaging studies have found that painful OA knee joints 
exhibit more MRI abnormalities than non-painful OA joints. Pathological findings in MRI studies 
are synovial hypertrophy and synovial effusions as well as subchondral bone marrow oedema [1]. 
These data and the observation of inflammatory cells in the sublining tissue may provide evidence 
that OA pain is evoked by recurring inflammatory episodes. At later stages capsular fibrosis and 
muscle contracture around the joint may contribute to OA pain [30]. Furthermore, whole-knee 
synovitis assessed by contrast-enhanced MRI has been found to be strongly associated with 
tibiofemoral radiographic OA and MRI-detected widespread cartilage damage [31]. Also, 
inflammation in the infrapatellar fat pad is associated with knee OA pain [32]. 
Despite significant advances in the understanding of the pathology of knee OA, pain 
pathology associated with knee OA remains largely unknown [33]. 
 
Joint pain  
Pain has been defined by the International Association of Pain (IASP) as ‘an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage or described in terms 
of such damages’ [34]. This definition emphasises the inherent subjectivity of pain, with both 
sensory and affective dimensions, that is not necessarily associated with tissue damage. 
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Pain is the most prominent and disabling symptom of OA [1] and a major clinical problem 
[35]. At a younger age particularly inflammatory diseases, such as rheumatoid arthritis, cause joint 
pain, whereas elderly people mainly suffer from pain due to OA.  
Overall, pain from OA seems to be more frequent than pain from inflammatory joint 
disease [35]. However, concerning neuronal mechanisms of joint pain much more information is 
available on inflammatory joint pain. There are a number of reasons for these discrepancies. First, 
it is presently ill-defined under which conditions OA pain occurs. In most cases OA is a slowly 
progressing disease, and it is unclear at which stage the joint becomes painful. Second, the 
pathogenesis of OA pain is unclear [11] and the diagnosis is unspecific reflecting a set of clinical 
features rather than specific (identified) biological (pathological) processes. 
 
Joint nociception and sensitisation (from periphery to central manifestations) 
Pain in arthritis is characterised by hyperalgesia and spontaneous pain (pain at rest). Hyperalgesia 
means that the application of noxious stimuli causes stronger pain than normal and that pain is 
even evoked by stimuli whose intensity is normally not sufficient to elicit pain. It is thought that 
this heightened pain sensitivity results from sensitisation in the nociceptive system [12;36;37]. 
 
Pain pathways 
Nociception is the neural process involving the transduction and transmission of noxious stimulus 
to the brain via a pain pathway [38-40]. Nociceptors are the receptors found in most tissues 
including skin, deep somatic tissues (e.g. muscles and joints) and the viscera [40], which are 
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activated specifically by noxious stimuli. The ‘noxious’ information is mediated by primary afferent 
neurons from the periphery to the central nervous system along axons [39]. 
Inflammatory substances change the response properties of the nociceptors, activating and 
sensitising them (peripheral sensitisation) [10;37]. Nociceptors are free nerve endings of nerve 
fibres [12;37]. There are three fibre types: Aβ- (group II), Aδ- (group III) and C-afferent fibres 
(group IV). These primary afferent nerve fibres have cell bodies in either the dorsal root ganglia or 
trigeminal ganglion and terminate in the dorsal horn of the spinal cord. The dorsal horn of the 
spinal cord is the site where the primary afferent fibres synapse with second-order neurons. It is 
also the site where complex interactions occur between excitatory and inhibitory inter-neurons 
and where descending inhibitory tracts from higher centres exert their effect [38-41].  
The different fibre types in the joint nerves differ with regard to their mechanosensitivity. 
Most fibres in the proprioceptive Aβ-fibre range respond to innocuous movements of the joints, 
whereas a large number of the nociceptive Aδ and C fibers show thresholds in the noxious range 
(rotation of the joint against the resistance of the tissue and intense local pressure). A large group 
of mainly C fibres constitute so-called silent nociceptors, because they do not even respond to 
noxious mechanical stimuli of the normal joint. They respond to mechanical stimulation during 
inflammation of the joint [11]. These neuronal changes represent a plausible explanation for the 
occurrence of mechanical hyperalgesia or pain in the inflamed joint [10;11].  
Individual differences in transmission and modulation of nociceptive information by the 
peripheral and central nervous system are one factor that may contribute to OA symptoms. 
Historically OA has been considered a peripheral disease (i.e., nociceptive damage at the knee) 
[42]; however, central mechanisms that modulate pain contribute importantly to OA 
symptomatology [43]. The influence of these central mechanisms can be observed by assessing 
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perceptual responses to quantifiable noxious stimuli at the knee (primary hyperalgesia) and in 
areas remote to the knee (secondary hyperalgesia).  
 
Peripheral sensitisation  
Tissue injury is followed by a cascade of events involving primary sensory afferents, sympathetic 
efferents, white blood cells and platelets that induce peripheral sensitisation [39]. Peripheral 
sensitisation is induced within the first hours after onset of inflammation and can persist over 
weeks [12].  
During inflammation joint nociceptive spinal cord neurons (primary afferent neurons) with 
joint input  are substantially sensitised for mechanical stimuli applied to the joint [11;12;36]. The 
consequence of these processes is that, under inflammatory conditions, the nociceptive system 
develops a state of hyperexcitability consisting of enhanced responses to mechanical stimulation 
of the joint (in the innocuous and noxious range), thereby lowering the excitation threshold in 
high-threshold neurons. Furthermore, the neurons begin to show increased responses to stimuli 
applied to regions adjacent to and remote from the joint, and the total receptive field can exhibit 
enlargement. These changes underlie primary hyperalgesia and secondary hyperalgesia [11;29;36].  
 
Facilitated central mechanisms  
Damage of peripheral tissue and injury to nerves typically cause persistent pain and hyperalgesia. 
Recent evidence indicates that hyperalgesia depends, in part, on central sensitisation [44]. The 
term central sensitisation is used to describe the phenomena of wind-up, long-term potentiating 
and secondary hyperalgesia [39].  
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During the development of inflammation in the joint, neurons in the spinal cord, with input 
from the inflamed joint, are rendered hyperexcitable [11;12;45]. Thus, inflammation induces 
neuroplastic changes in the spinal cord, which alter nociceptive processing and lead to facilitation 
of spinal neuronal processing of the afferent fibres. This leads to increased sensitivity or reduced 
thresholds to non-noxious pressure on the inflamed joint [11;13;29] and, with some delay, to the 
adjacent and non-inflamed tissue; the latter indicating that spinal neurons expand their receptive 
fields [12;13;29;41;44;45]. The fact that pain and hyperalgesia can spread to areas far from the 
injured region implies that central changes, as opposed to simple convergence, are involved in the 
spread of hyperalgesia. Other features of facilitated central mechanisms, where the central 
integrative mechanisms are up-regulated [13], include facilitated temporal and spatial summation 
of pain [46]. 
At least at advanced stages of OA, patients show signs of facilitated central mechanisms. 
They often report widespread pain beyond the OA joint and exhibit lower pressure pain thresholds 
in cutaneous and subcutaneous structures of the whole leg [36]. In addition, patients with strong 
local hyperalgesia at the OA knee joint exhibit higher pain summation scores upon repetitive 
stimulation of the OA knee. The mechanisms of central sensitisation can be very complex, and 
central sensitisation during OA in particular has not been extensively studied [36;44;47]. 
Assessment of facilitated temporal summation of pain might shed light on the role of peripheral 
and central mechanisms in the sensitisation phenomena. 
 
Anatomical structures potentially involved in knee OA nociception  
Of the three compartments that combine to form the knee joint (the lateral tibiofemoral 
compartment, the medial tibiofemoral compartment and the patellofemoral compartment), the 
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medial tibiofemoral compartment is the most common site of knee OA [48], presumably reflecting 
of the distribution of the loading with the majority of the load being placed on this compartment 
[49]. 
The articular cartilage in an osteoarthritic knee is thinned, damaged or entirely disbanded. 
When the knee cartilage has deteriorated, new cartilage may be produced; however, the new 
cartilage cells may grow in irregular, bumpy patterns rather than in the original smooth form. To 
compensate for the deteriorated or missing cartilage the bones in the joint may produce small 
bony growths called osteophytes or bone spurs [42;50-52]. It is important to note that cartilage 
does not contain nerves; hence, damaged cartilage is not a source of pain in knee OA. Likewise, 
bone spurs are a normal sign of aging, and the presence of bone spurs alone is not a concern. 
However, the friction between bones and other resulting abnormalities in the knee may cause 
discomfort and pain [42;50-52]. 
All innervated tissues inside and around the knee joint represent potential pain generators 
in knee OA. In addition, nerves themselves - not only peripheral nerves, but also central nervous 
system - plays a significant role in pain mechanisms in knee OA [37]. Although the main source of 
pain in knee OA is intra-articular structures, extra-articular sources are not negligible, especially in 
older patients with a long history of diffuse pain [53]. These differences in pain characteristics in 
knee areas should be taken into account when examining the pain sources of knee OA [53]. 
 
Current perspectives on knee OA pain 
Musculoskeletal pain is typically described by patients as a drilling, tight, radiating and diffuse pain 
sensation with pain referrals, and it is often accompanied by deep-tissue hyperalgesia or allodynia 
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[54]. Pain localisation in deep tissue is poor, and it is difficult to differentiate between pain arising 
from muscles, tendons, ligaments and bones and pain arising from joints and their capsules [55]. 
Pain is the cardinal symptom of knee OA, and currently this disease cannot be cured. 
Altered pain sensitivity is most likely related to increased sensitivity of peripheral nociceptors 
and/or central neurons [1;12-14], and it is well known that inflammatory joint diseases lead to 
both peripheral and central sensitisation of the nociceptive system [14;45].   
Inflammation plays a fundamental role in the pathogenesis of knee OA, and there is 
growing consensus that knee OA involves low-grade inflammation contributing to structural 
disease progression and generation and maintenance of pain [56-58]. Synovial inflammation acts 
as a trigger for several signs and symptoms of OA, including stiffness, effusion and joint swelling, 
and has profound effects on the nociceptive system where cytokines seem to be a major player in 
the production of such effects [56;57].  
Intra-articular steroid injections have beneficial short-term effects on pain and are widely 
used in clinical practice [17]. However, factors that predict response are poorly characterised, 
making it difficult to select the patients for whom treatment is most likely to be successful. 
Although the mechanism of the therapeutic effect in knee OA is unclear, it is likely to be related to 
the potent anti-inflammatory effect of steroid. It is unknown whether the anti-inflammatory 
effects of intra-articular steroid influence the increased pain sensitisation phenomena in patients 
with knee OA is.  
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Figure 3 The manual pressure algometer 
with stop-button and calibration weights. 
Assessment of pain mechanisms in knee pain  
Over the last couple of decades quantitative sensory testing (QST) has emerged as a promising 
means for monitoring and diagnosing pain processing and its alterations in patients [59;60]. 
Quantitative pain assessment is performed using different methods typically involving 
psychophysical testing [13]. The technique is based on the application of defined stimuli to the 
individual under standardised conditions, subsequently asking the participant to rate the 
experienced intensity of the stimuli. The use of multiple stimuli with different intensities makes it 
possible to construct a stimulus-response relationship characterising the state of the participant’s 
pain processing.  
 
Manual pressure algometry 
The manual pressure algometry (Figure 3) method yields information about mechanical pressure 
pain thresholds (PPT), which can be used for quantitative evaluation of subjective pain reactions 
from different tissue structures [61], as well as information about the adaptive response to tonic 
pain. Manual algometry has been widely used across several conditions such as OA [62-64], 
myofascial pain syndrome [65;66], fibromyalgia [67;68] and chronic back pain [69;70]. Clinical 
studies in knee OA have reported generally acceptable reliability of manual algometry [71-73]. 
Thus, while manual algometry seemingly has good reliability, it is highly operator dependent, and 
correct application requires training and thorough instruction of both patient and operator [74].  
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Figure 4 The computerized controlled 
pressure algometer, including compressor 
and control panel, a stop-button, and a 
visual analogue scale. 
Computer-controlled pressure algometry 
The variability associated with manually-applied pressure stimulation can be minimised through 
the use of computer-controlled pressure stimulation (Figure 4). It is an easy method which also 
allows for the measurement of stimulus-response functions that relate the pressure intensity to 
the pain response [75;76]. In response to a sequence of somatosensory stimuli with the same 
intensity, the progressive increase in pain perception is defined as the temporal summation of 
pain, which mimics the initial phase of the wind-up process [13;77]. Appropriate conditions for the 
assessment of temporal summation are sufficiently short intervals between repeated stimuli of 
constant strength (such as 10 stimuli at 1 s inter-stimulus intervals) [64;77-79]. This procedure was 
used in the present thesis. In line with manual algometry this method has been used across 
several conditions such as fibromyalgia [80;81], OA [82], and  healthy subjects [83;84]. 
 
 
 
 
 
 
 
 
Computerised cuff pressure algometry (Cuff) 
Cuff algometry methodology has been used for quantifying pain sensitivity in the lower legs and 
arms (Figure 5). Assessments of pressure pain sensitivity include determination of pressure pain 
thresholds and spatial and temporal summation of pain [85-87]. The cuff algometer will activate a 
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Figure 5 The computerised cuff pressure 
algometer, including compressor and 
control panel, inflatable cuff, and a stop-
button with integrated visual analogue 
scale. 
larger volume of the deep somatic tissue than manual and computer-controlled pressure pain 
algometers and is less influenced by local pain sensitivity variations.  
 
 
 
 
 
 
 
 
Explanatory variables  
Besides those variables acquired in the above-mentioned pain sensitivity methods (PPT and 
temporal summation), profiling widespread pain in clinical studies requires detailed descriptions of 
the habitual pain distribution, quality and intensity; valuable tools for achieving this include scales, 
pain drawings and questionnaires. This thesis includes several measures considered to be of 
important explanatory value in the analysis of the effect of pain modulation on pain sensitivity. 
 
Pain intensity 
For the evaluation of knee OA pain, visual analogue scale (VAS) and numerical rating scale (NRS) 
assessments of pain intensity are the most common – a single question about the presence of 
‘pain, aching of stiffness in or around the knee’ over a specified period of time [21], which has 
been validated as an appropriate pain instrument for OA [88]. In the present thesis a single 
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question about the presence of ‘pain’ in different situations of pain modulation was used, defined 
as current knee pain in which ‘0 cm’ represents no pain and ‘10 cm’ represents maximal pain. 
 
Pain distribution 
The distribution of pain was drawn on an anatomical map. Knee pain was defined as local pain. 
Pain occurring in thighs, calves, and feet was defined as widespread pain. 
 
Pain description 
The quality of the pain was described using both an English [89;90] and a Danish version of the 
McGill Pain Questionnaire (MPQ) [91] to explore and identify the individual’s use of descriptors to 
characterise the experience of pain modulation. Clinical studies in different populations have used 
the MPQ [90;91]. The questionnaire has been validated as an appropriate pain instrument for use 
in OA [88]. The results of the study by Drewes et al. [91], translating the MPQ into a Danish version 
and making comparisons to studies of patients speaking other languages, allowed us to use the 
questionnaire in both an English-speaking and a non-English-speaking population. 
 
Knee Injury and Osteoarthritis Outcome Score (KOOS) 
The KOOS questionnaire was developed as an instrument for assessing the patient’s opinion about 
their knee and associated problems. KOOS is self-explanatory, can be easily administered and has 
been used in different populations [82]. Furthermore, it is widely used for research purposes in 
clinical trials, large-scale databases and registries and it has high test-retest reliability [92].  
21 
 
KOOS consists of five subscales: Pain, Symptoms, Activities of daily living, Sport and 
recreation function, and Knee-related quality of life. Standardised answer options are given (5 
Likert boxes) and each question is scored from 0 to 4. A normalised score (100 indicating best 
condition and 0 indicating worst condition) is calculated for each subscale [93]. KOOS is a 
developmental variant of the WOMAC questionnaire, which was intended for assessment of 
elderly people with primary OA [94].  
 
Experimental models of knee pain  
Knee OA is a chronic pain condition, but it is also characterised by other factors (e.g. inactivity and 
joint degeneration). Experimental models of knee pain in healthy subjects may be advantageous in 
the investigation of mechanisms of the nociceptive system related to joint pain. In several studies 
sensitisation of deep-tissue nociceptors has been demonstrated by injection of algesic substances 
or external nociceptive stimuli inducing hyperalgesia [54;95-99]. In addition, both spreading 
hyperalgesia and hypoalgesia have been reported to occur in different tissues after experimental 
pain [96;97]. Few human experimental knee joint pain models exist, among which injection of 
hypertonic saline into the infrapatellar fat pad [100-105] is adequate for studies of sensory 
manifestations related to knee pain. The experimental muscle pain technique as a knee OA model 
may be criticised, as muscle tissue is not the source of primary pain in knee OA [103;106]. 
Experimental knee pain is an alternative model.  
The infrapatellar fat pad is an intra-articular structure, sensitive to mechanical stimulation, 
and densely innervated by nociceptors [107;108]. Adipose tissue is a metabolically active 
endocrine organ that can secrete agents associated with the production of pro-inflammatory 
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cytokines found in synovial fluid in knee OA joints [109]. Thus, adipose tissue may play a central 
role in the inflammatory processes of OA.  
Change in MRI-detected synovitis in the infrapatellar fat pad are associated with changes in 
knee OA pain [32;110], and the infrapatellar fat pad may be an important structure to consider in 
the aetiopathogenesis of knee OA and knee OA pain [32;111]. Furthermore, experimental studies 
have shown that experimental pain in the infrapatellar fat pad elicits changes in motor function 
similar to those observed among knee OA patients [101;103].  
Thus, experimental infrapatellar fat pad pain is presumably a more valid model of knee OA 
pain than muscle pain models, but it is unknown whether experimental pain in the infrapatellar fat 
pad leads to peripheral and/or central sensitisation similar to that observed in knee OA patients 
[64].  
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Figure 6 Changes in current 
knee pain intensity in knee 
OA patients at baseline, 
immediately after the intra-
articular treatment, and at 
follow-up (study ii). 
Changes in pain intensity and sensitivity by injection of local knee joint analgesia  
The management paradigm for pain in OA has changed little over many decades. However, recent 
studies have shown that long-term use of standard treatments, including acetaminophen and 
nonsteroidal anti-inflammatory drugs, fails to reduce mean pain levels beyond minimal clinically 
important thresholds [112;113]. One potential explanation for suboptimal pain control in OA may 
be a mismatch between the medications used and the underlying pain mechanism(s) [113].  
To predict the response of an analgesic and anti-inflammatory treatment it is important to 
have a better understanding of the pain sensitisation phenomena in patients with knee OA and 
the possible effects. 
 
Local knee joint analgesia and knee OA 
There is growing consensus that knee OA pain involves a low-grade inflammation [56;57], and the 
mechanism of the therapeutic effect in knee OA is likely to be related to the potent anti-
inflammatory effect [17]. There is evidence of short-term benefit of intra-articular anesthetic 
injections [114] or of intra-articular glucocorticosteroid injections with pain relief for up to 4 weeks 
[17;115].  
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Besides the important effects on 
the patient’s reported pain intensity 
(current knee pain), intra-articular 
treatment also had important clinical 
effects on pain sensitivity. In study (ii) 
the effects of intra-articular treatment 
have led to immediate higher PPTs 
(reduced pain sensitivity) at the knee 
and surrounding muscles (study ii). The 
effect was sustained for 2 weeks after 
the injection (Figure 7), supporting the 
proposed involvement of inflammation 
in the sensitisation phenomena. 
Figure 7 Mean PPTs at the knee (infrapatellar fat pad), 
the surrounding muscles (vastus lateralis and tibialis 
anterior), and at the contralateral arm before and two 
weeks after the intra-articular treatment (study ii). 
Clinical studies have documented inflammation in the synovium and other intra-articular 
structures of OA knees contributing to the sensitisation of pain [29]. In line with previous 
observations [17], the results from study (ii) have demonstrated reduced current knee pain 
intensity immediately after, and two weeks after  the intra-articular treatment leading to 
significantly lower VAS scores (reduced pain intensity) (Figure 6). 
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Clinical pain improvement is influenced by a wide range of parameters, including 
nociception, psycho-social factors, and affections [116;117]. The lack of association between pain 
sensitivity (PPT), pain sensitivity changes, and pain improvements in study (ii) could be explained 
by the difference in the constructs of the pain assessment types; e.g. PPTs are based on instant 
painful stimulation. This is in contrast with previous findings in which higher pre-operative 
widespread  hypersensitivity may be associated with chronic pain after total knee replacement 
[118]. Some patients with OA experience pain sensitisation [119], which has the potential to 
become a risk factor for chronic pain after total knee replacement [120]; however, the patients in 
the present thesis were not candidates for surgery. 
The reduced pain sensitivity observed after the clinical pain relief treatment in study (ii) 
was not confined to the lower extremity, as a trend towards reduced pain sensitivity was observed 
at the control site on the contralateral arm. No definitive models explaining the transition from 
localised to widespread musculoskeletal pain conditions exist, but it has been shown that initial 
excitation and sensitisation of peripheral nociceptors (e.g. due to joint inflammation) may cause 
sufficient input to the central pain systems [54;121;122]. The local and widespread effects 
observed in study (ii) support the notion that input from intra-articular structures may contribute 
to widespread hyperalgesia and that anti-inflammation may reverse it. 
Further, widespread hypersensitivity in mechanical pressure pain and loss of pain 
modulation in patients with symptomatic knee OA were shown to normalise after knee joint 
replacement [122]. Also, therapeutic exercise has been shown to yield similar effects on pain 
sensitivity [82]. The present study (ii) corroborates these findings, indicating that simple analgesia 
and anti-inflammation reduce widespread hypersensitivity in mechanical pressure pain. 
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Figure 8 Changes in KOOS questionnaire two weeks after the intra-articular 
treatment (study ii). 
The intra-articular treatment also had a general beneficial effect on self-reported knee 
related disease impact, as assessed by KOOS [123], although only reaching statistical significance 
in the symptoms’ sub-domain (Figure 8). These results are in line with the meta-analysis by 
Bellamy et al. [115] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inflammation and knee OA 
It is well known that inflammatory joint diseases lead to both peripheral and central sensitisation 
of the nociceptive system [14;45;124], and the results from study (ii) may support the proposed 
involvement of inflammation in the sensitisation phenomena as the effects were sustained for at 
least 2 weeks at both the knee and the surrounding muscles (Figure 6 & 7). 
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Synovial inflammation acts as a trigger for several signs and symptoms of OA, including 
stiffness, effusion and joint swelling [56], and has profound effects on the nociceptive system, 
where cytokines seem to be a major player in the production of such effects [57]. Clinical studies 
have shown significant inflammation in the synovium and other intra-articular structures of OA 
knees, contributing significantly to the sensation of pain [29]. Changes in synovitis in the 
infrapatellar fat pad were detected by MRI and those changes were associated with changes in 
knee OA pain [110;125].  
In the present thesis clinical pain relief induced by an intra-articular analgesia and anti-
inflammatory treatment yielded beneficial effects on both local and widespread hyperalgesia (ii), 
indicating that inflammation does indeed affect pain sensitivity and seems to play an important 
role in the pain sensation of the persons with knee OA included in this study.  
 
In summary 
Intra-articular analgesia and anti-inflammatory treatment reduced localised and widespread pain 
sensitivity in patients with knee OA. The effects were immediate and were sustained for at least 2 
weeks. Furthermore, this thesis supports the notion that inflammation may play an important role 
in the sensitisation of the nociceptive system in both joint and soft tissues in knee OA. 
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Changes in pain sensitivity and intensity evoked by experimental knee pain 
The infrapatellar fat pad has been shown to be an active osteoarthritic joint tissue that is able to 
produce and excrete important inflammatory mediators directly into the knee joint, which might 
explain the role of the infrapatellar fat pad in the disease process of knee OA [108]. In the study by 
Hill et al. [110] synovitis was scored at three different locations. MRI-detected change in synovitis 
was correlated with changes in knee pain. The increase in synovitis was associated with worsening 
knee pain, and a decrease with less severe pain. These results indicate that the infrapatellar fat 
pad is a significant source of knee OA pain, suggesting that the treatment of painful OA of the 
knee should be targeted at synovitis, which may relieve pain.  
Experimental pain may not replicate ‘real’ OA pain although several studies [100;101;103-
105] have found that experimental pain induced into the infrapatellar fat pad produced strong 
knee pain in regions similar to those in patients with knee OA.  
 
Pain intensity 
Hypertonic saline caused significantly higher pain intensity compared with isotonic saline in both 
healthy subject (i) and in knee OA patients (iii) (Figure 9), supporting observations previously 
reported in healthy subjects.  
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Figure 9 Current knee VAS pain after injection of hypertonic saline in healthy subjects (A; study i) and patients with 
knee OA (B; study iii) and isotonic saline as control. In both figure A and B there were significant differences 
between hypertonic and isotonic saline.  
 
Several studies have found that, in healthy subjects, experimental pain induced into the 
infrapatellar fat pad produced intense knee pain in regions similar to those in patients with knee 
OA [100;101;103-105;126], indicating that the experimental model behaves similarly in healthy 
subjects and in patients with knee OA. 
 
Pain distribution 
This is the first time experimental pain has been induced in the infrapatellar fat pad in individuals 
with knee OA (iii). In previous studies on healthy subjects experimental pain was described as local 
pain in the region medial to the patellar tendon around the injection site [13;64;100]. Study (i) 
corroborates these findings, although the subjects also reported central and lateral pain as well as 
referred thigh pain.  
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Figure 10 Illustrating pain 
distributions before (A) and after 
injection of hypertonic saline (B) in 
patients with knee OA (study iii).  
The individuals with knee OA described the experimental pain areas as being larger 
compared with their habitual OA knee pain (Figure 10) as well as having referred pain to the thigh 
and lower leg, which is in contrast to studies using the experimental pain model in healthy 
subjects; here the experimental pain areas are smaller [13;64;100;126]. The larger areas may 
indicate that the patients with knee OA have a facilitation of mechanisms linked with referred pain 
as suggested previously [13;62;127].  
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Figure 11 Illustrating pain 
distribution after injection of 
hypertonic saline in patients with 
knee OA (A; study iii) and healthy 
subjects (B; study i) 
The pain areas described by the individuals with knee OA in study (iii) were comparable to 
the pattern described by the healthy subjects in study (i) and in line with similar experimental 
knee pain models in healthy subjects [100-102;126], although to a greater extent (Figure 11). This 
could indicate that individuals with knee OA are sensitised, even after anti-inflammatory 
treatment. 
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Table 1: Words describing the quality of pain before (before knee OA), and after 
induction of hypertonic saline in patients with knee OA (after knee OA) and in 
healthy subjects (after healthy). Words used ≥3 times by the participants has 
been included in the table (knee OA; study iii and healthy; study i). 
Pain description  
When describing the experimental pain in the present thesis, the healthy subjects in study (i) and 
individuals with knee OA in study (iii) used similar words (Table 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cumulative data suggest that people with OA can experience pain caused by both 
nociceptive and neuropathic mechanisms to varying degrees [128;129]. The likely neuropathic 
mechanism in OA is central sensitisation, which may arise from chronic nociceptor stimulation and 
subsequent modification of central pain-transmitting neurons [130].  
 
Subclasses  
 
Before  
(knee OA) 
 
After 
(knee OA) 
After 
(healthy) 
Sensory descriptors: 
               Throbbing 
               Shooting 
               Drilling 
               Sharp 
               Tugging 
               Wrenching 
               Burning 
               Smarting 
               Dull 
               Sore 
               Hurting 
               Aching 
               Taut 
 
 
N=3 
 
N=3 
 
 
N=3 
N=3 
N=3 
N=3 
 
 
 
N=3 
 
 
N=3 
N=4 
 
N=4 
 
 
 
N=4 
 
 
 
N=4 
 
 
 
N=3 
N=4 
 
 
 
 
N=4 
N=3 
N=4 
Affective descriptors: 
                Tiring 
Cruel 
 
 
N=3 
 
 
N=4 
N=3 
 
N=3 
Evaluative descriptors:  
                Annoying    
                Miserable 
                Intense 
 
 
N=3 
 
 
 
N=3 
N=3 
N=4 
Miscellaneous descriptors: 
               Penetrating 
               Piercing 
               Tight 
 
 
 
 
 
 
N=6 
 
N=3 
N=4 
N=4 
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Figure 12 Hyperalgesia 
(A) and facilitated 
temporal summation of 
pain (B) at the 
infrapatellar fat pad 
after injection of 
hypertonic saline in 
healthy subjects. In 
both figure A and B 
there were significant 
differences between 
hypertonic and isotonic 
saline (study i). 
A recent focus group study on the hip/knee OA pain experience identified that participants 
used a broad range of descriptors to characterise their pain [131] which is in line with the present 
study (iii). A focus group study by Hochman et al. [113] found that 34% of knee OA participants 
used pain quality descriptions suggestive of neuropathic pain. Neuropathic mechanisms may 
therefore contribute to the pain experience of a subset of adults with chronic, symptomatic knee 
OA. The use of both neuropathic and nociceptive descriptors by some of the individuals suggests 
that OA can be associated with a mixture of pain mechanisms [113]. This might be part of the 
reason why the healthy subjects and the individuals with knee OA used different words to describe 
the experimental pain.  
 
Experimental knee pain and healthy subjects 
Experimental approaches using healthy subjects provide a unique opportunity to study the pain 
pattern arising from nociceptive stimulation of specific structures without any influences from 
other conditions related to knee pathology (e.g. inflammation, co-morbidities, central sensitisation 
etc.).  
In study (i) the experimental knee pain model showed that hyperalgesia and facilitated 
temporal summation of pressure pain were found at the knee (figure 12; A&B) and knee-related 
muscles. 
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The increased sensitivity was exclusive to deep tissue, and no changes in decreased pain 
sensitivity were found for either cutaneous or contralateral pain sensitivity. The hyperalgesia 
induced by experimental knee pain in study (i) has also been identified in different tissues induced 
by different analgesic substances in healthy subjects [54;79;95-99]. The pain induced by 
hypertonic saline occurs immediately and is not associated with tissue damage or toxicity [132]; 
thus no inflammatory reactions in the tissue are present.  
In addition, the findings in study (i) show that pain from normal tissue, without 
interference from inflammation, can elicit facilitation of central mechanisms in healthy subjects, as 
facilitated temporal summation of pressure pain in the infrapatellar fat pad and in muscles located 
distant to the actual experimental pain site was observed. These results indicate enhanced 
sensitivity of the central mechanisms responsible for temporal summation of pain. In line with 
study (i), previous studies have reported mechanically stimulated facilitated temporal summation 
of pain in muscles in healthy subjects after induction of experimental pain [77;133;134].  
In patients with knee OA facilitated temporal summation was found in both the same 
segment and the neighbouring segment and at the contralateral site [64]. This is in contrast with 
the findings in study (i), as we did not find facilitated temporal summation at the contralateral leg. 
The discrepancies between the two studies might be caused by the fact that facilitated central 
mechanisms in neighbouring segments seen in knee OA patients occur over time [13] and by the 
fact that the excitation and sensitisation of nociceptors, due to tissue damage, might cause 
sufficient nociceptive input to the central pain systems to initiate central sensitisation.  
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Figure 13 Hyperalgesia (A) and facilitated temporal summation of pain (B) at the infrapatellar fat 
pad after injection of hypertonic saline in patients with knee OA (study iii). 
Experimental knee pain and knee OA 
Earlier studies have suggested that knee OA patients generally have higher pain sensitivity 
compared to controls [62;63;119] indicating defects in central pain processing. 
 Local hyperalgesia (Figure 13A) to pressure stimulation during experimental knee pain (as 
compared with the control injection) in clinical pain-relief treated patients with knee OA was 
observed in study (iii), in line with those observed in healthy subjects [63;126] and in individuals 
with knee OA [62] suggesting facilitated pain mechanisms.   
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These findings corroborate findings by Rakel et al. [63] , where hyperalgesia to pressure 
stimulation was observed at the affected knee but not at distant sites, but in contrast to studies 
measuring PPTs in participants with advanced knee OA pain showing significantly lower PPTs at 
the effected knee and also at distant sites compared to controls [15;64]. The reason for this 
discrepancy could be related to the severity of the pain which was mild in the present study  
The experimental knee pain in study (iii) also facilitated temporal summation of pressure 
pain (as compared to the control injection) at the knee (Figure 13B) and adjacent muscles located 
proximally and distally to the actual experimental pain site, which is in line with observations 
previously seen in clinical studies [64;86;135;136] and among the healthy subjects in study (i) This 
indicates an enhanced sensitivity of the central mechanisms responsible for temporal summation 
of pain.  
The results in study (iii) indicate that the dynamics (i.e., the adaptive responses to pain) of 
the nociceptive system is intact among individuals with knee OA, as the responses to experimental 
pain are similar to those previously observed from healthy subjects, showing that the pain system 
in individuals with knee OA can be affected even after many years of nociceptive input. The 
rekindled hyperalgesia caused by the experimental pain model indicates that the sensitisation is 
latent despite the effect of the pain-reducing treatment, which is suggestive of more persistent 
plastic changes in the central nervous system with chronic pain. 
No previous studies have shown the enhanced pain sensitivity mechanisms in painful but 
otherwise healthy knees reported in study (i), indicating that the infrapatellar fat pad pain may 
contribute significantly to hyperalgesia and sensitisation phenomena and offer a potential 
mechanism in individuals with knee OA. Furthermore, it has been suggested that knee OA pain 
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may result from mild inflammation in structures such as synovial layers [11], and the infrapatellar 
fat pad may also be involved [108].  
 
In summary 
Acute experimental knee pain induced in healthy subjects and individuals with knee OA leads to 
hyperalgesia and facilitated temporal summation in the knee and surrounding muscles. This was 
regardless of whether the individuals with knee OA had received pain-reducing treatment before 
the induced experimental pain.  
The present thesis illustrates that the dynamics of the nociceptive system (i.e., the adaptive 
responses to pain) was intact in individuals with chronic knee OA pain, as the responses to 
experimental pain are similar to those previously observed among healthy subjects, showing that 
the pain system in individuals with knee OA can be affected even after many years of nociceptive 
input. The experimental knee pain model used in this thesis may be valuable for assessing the 
effects of pain modulation of both local and facilitated central mechanisms related to knee OA.  
 
Limitations 
Important limitations to the present thesis are the short-lasting and highly-controlled 
experimental pain stimulus in study (i), which provides a different pain experience than the 
chronic pain condition of individuals with knee OA. Nevertheless, the experimental approach 
offers the translation from fundamental mechanisms to clinical implications. The lack of a control 
group in study (ii) is another limitation of this thesis. Thus, placebo effects in study (ii) cannot be 
ruled out, and placebo might explain the immediate increase in PPT at the control site post- 
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injection. Furthermore, it has been shown that intra-articular local anesthetic have analgesic 
effects for up to 7 days [114], which may confound our findings somewhat. Lack of power (small 
sample size) in studies (ii) and (iii) may have precluded detection of statistically significant 
associations. However, these data are the first of their kind and constitute important stepping 
stones for future investigations.  
The weaknesses of the design were compensated for by adding an extra baseline test to 
assess measurement stability and regression to the mean phenomena before intervening in study 
(ii). Intra-session analyses were conducted to explore a possible significant difference between the 
two baseline tests in all the analyses, and no significant differences were found (data not shown). 
Also, the results were robust across multiple methods, assessing pain sensitivity locally and 
regionally, and with different methods of pressure application (computer-controlled vs. manual). 
This adds strength to the current findings despite the small sample size and uncontrolled study 
design.  
 
Concluding remarks  
The present work has showed that experimental knee joint pain leads to hyperalgesia and 
facilitated temporal summation of pain, not only in the infrapatellar fat pad, but also in muscles 
located distant to the injection site, in subjects with no history of knee pain. The changes observed 
suggest involvement of both local and widespread hyperalgesia and sensitisation of facilitated 
pain mechanisms similar to those observed among knee OA patients, indicating that the 
infrapatellar fat pad pain may contribute significantly to the sensitisation phenomena seen in knee 
OA patients.  
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The results reported in the present work indicate that the intra-articular analgesia in 
patients with knee OA lead to reduced pain sensitivity at the knee and surrounding muscles, and 
this effect was sustained and even augmented by the anti-inflammatory treatment of intra-
articular glucocorticosteroid, as shown by assessment of the effects 2 weeks after injection. No 
significant changes in pain sensitivity were observed at the control site on the contralateral arm, 
suggesting that local and widespread hyperalgesia is regulated by nociceptive input from the joint 
periphery. 
Reducing knee OA pain with intra-articular analgesia and anti-inflammatory treatment 
reduced the degree of knee hyperalgesia. These results might support the notion that 
inflammation may play an important role in sensitisation of the nociceptive system in both joint 
and soft tissues in knee OA. Experimental knee pain induced in the infrapatellar fat pad in the 
same patient evoked local and widespread hyperalgesia in the infrapatellar fat pad and in muscles 
located distant to the injection site as seen in healthy subjects. This illustrates that the dynamics of 
the nociceptive system (i.e., the adaptive responses to pain) was intact in individuals with chronic 
knee OA pain, as the responses to experimental pain are similar to those previously observed 
among healthy subjects, showing that the pain system in individuals with knee OA can be affected 
even after many years of nociceptive input. The experimental knee pain model might be valuable 
for assessing the effects of pain modulation of both local and widespread pain mechanisms related 
to knee OA.  
Although knee OA is a chronic pain condition associated with increased pain sensitivity, this 
thesis indicates that the adaptability of the pain system is intact, making it possible to prevent the 
development of centralised pain syndromes. The novel results of the studies illustrate the 
dynamics of the nociceptive system in individuals with knee OA, which might contribute to a 
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better understanding and development of more rational therapies of the central pain 
mechanisms, when targeting pain relief in individuals with knee OA. 
 
Perspectives 
Despite the high prevalence of knee OA it remains one of the most frequent knee disorders 
without a cure. Pain and disability are prominent clinical features of knee OA. Therefore, pain 
therapy is an important medical need which is rarely met. Still, many patients undergo surgical 
joint replacement after many years of pain. Thus, it is very important to improve our knowledge of 
pain generation in knee OA, with the hope of finding better treatment strategies.  
 
41 
 
Summary 
Pain is the cardinal symptom of knee osteoarthritis (OA), and currently this disease cannot be 
cured. Pain and disability are prominent clinical features of knee OA.  
Some of the mechanisms underlying the pain are unknown. To optimally treat this common 
disease, an understanding of the causes of pain is needed. Especially, knowledge of how joint pain 
affects the pain systems will provide important new insight and help to explain the basic pain 
mechanisms in humans. 
The acute experimental knee pain induced in healthy subjects in study (i) and individuals 
with knee OA in study (iii) leads to hyperalgesia and facilitated temporal summation in the knee 
and surrounding muscles, regardless of whether the individuals with knee OA had received pain-
reducing treatment before the induced experimental pain. This indicates that the dynamics  of the 
nociceptive system (i.e., the adaptive responses to pain) was intact in individuals with chronic 
knee OA pain, as the responses to experimental pain are similar to those previously observed 
among healthy subjects, showing that the pain system in individuals with knee OA can be affected 
even after many years of nociceptive input.  The experimental knee pain model used in this thesis 
may be valuable for assessing the effects of pain modulation of both local and facilitated central 
mechanisms related to knee OA.  
Hyperalgesia and facilitated central pain mechanisms observed in individuals with knee OA 
were reduced after injection of intra-articular analgesia and anti-inflammatory treatment in both 
the knee and surrounding muscles (ii). The effects were immediate and were sustained for at least 
2 weeks. This supports the notion that inflammation may play an important role in the 
sensitisation of the nociceptive system in both joint and soft tissues in individuals with knee OA. 
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The novel results of this thesis might contribute to a better understanding and 
development of more rational therapies of the central pain mechanisms, when targeting pain 
relief in individuals with knee OA. 
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Summary in Danish (Dansk resumé) 
Knæsmerter er blandt de hyppigste muskuloskeletale smerter, den hyppigste årsag til nedsat 
funktionsniveau og et kardinalsymptom ved knæ-artrose (knæ-OA). Nociception er den 
fysiologiske mekanisme, som omfatter alle neurale processer til bearbejdning af vævsskadelige 
påvirkninger, hvilket vil sige eksitation af bl.a. smertereceptorer. Smerte er et resultat af den 
nociceptive aktivering af fremmende og hæmmende systemers modaliteter, og hvordan den 
justeres ved bl.a. knæ-OA er endnu ikke helt klarlagt.  
Smerter ved knæ-OA kan være forårsaget af perifer og central sensibilisering af 
smertesystemerne, som resulterer i, at normale stimuli opleves som smertefulde. Formålet med 
afhandlingen er at belyse nogle af de mekanismer, der ligger til grund for knæsmerter. Mere viden 
er nødvendig for at forstå disse smerteproblemer. Specielt kræves større viden om, hvilke 
mekanismer der aktiveres ved dybe smerter. En sådan viden vil være værdifuld ved såvel 
smertebehandling som øvrige behandlinger af personer med knæ-OA. 
Smertesystemets reaktion på eksperimentel smerte induceret i fedtpuden lige under 
knæet i studie (i) medførte reduceret smertefølsomhed i knæet og de omkringliggende muskler 
hos raske forsøgspersoner. Denne er sammenlignelig med smertefølsomheden observeret hos 
personer med slidgigt i knæet. Disse resultater indikerer, at fedtpuden muligvis spiller en vigtig 
rolle i forbindelse med smertefølsomheden hos personer med knæ-OA.  
Intra-artikulær injektion af smertelindrende behandling til personer med knæ-OA i studie 
(iii) førte til væsentlig smertelindring i knæet og de omkringliggende muskler i op til 2 uger efter 
injektionen. Disse resultater tyder på, at betændelse i knæet kan spille en vigtig rolle i forhold til 
sensitisering af smertesystemet hos personer med knæ-OA. 
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Eksperimentel smerte påført de samme personer med slidgigt i knæet, som i studie (ii) 
havde modtaget en effektiv lindrende smertebehandling af deres knæsmerter, medførte både 
lokal (ved knæet) og udbredt (ved de omkringliggende muskler) forværring af smertefølsomheden 
(iii).  
Selvom knæ-OA er en kronisk smertetilstand associeret med øget smertefølsomhed (øget 
smerteoplevelse), indikerer resultaterne af afhandlingen, at smertesystemets tilpasningsevne er 
intakt, hvilket åbner op for muligheden for at udvikle behandlingsstrategier til personer med knæ-
OA, der forhindrer udviklingen af central sensitisering.  
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